AllianceBernstein’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2M | Sell |
1,944,020
-77,599
| -4% | -$1.08M | 0.01% | 797 |
|
|
2025
Q1 | $27.3M | Sell |
2,021,619
-265,375
| -12% | -$3.58M | 0.01% | 772 |
|
|
2024
Q4 | $43.8M | Buy |
2,286,994
+84,255
| +4% | +$1.62M | 0.01% | 634 |
|
|
2024
Q3 | $50.1M | Buy |
2,202,739
+204,547
| +10% | +$4.65M | 0.02% | 601 |
|
|
2024
Q2 | $26M | Buy |
1,998,192
+275,373
| +16% | +$3.58M | 0.01% | 797 |
|
|
2024
Q1 | $30.2M | Sell |
1,722,819
-336,645
| -16% | -$5.89M | 0.01% | 737 |
|
|
2023
Q4 | $44.9M | Buy |
2,059,464
+168,466
| +9% | +$3.67M | 0.02% | 618 |
|
|
2023
Q3 | $29M | Buy |
1,890,998
+316,696
| +20% | +$4.86M | 0.01% | 730 |
|
|
2023
Q2 | $37.5M | Buy |
1,574,302
+330,152
| +27% | +$7.85M | 0.02% | 660 |
|
|
2023
Q1 | $31.7M | Buy |
1,244,150
+320,317
| +35% | +$8.15M | 0.01% | 698 |
|
|
2022
Q4 | $27M | Buy |
+923,833
| New | +$27M | 0.01% | 751 |
|
|
2022
Q3 | – | Sell |
-50,479
| Closed | -$584K | – | 3298 |
|
|
2022
Q2 | $584K | Buy |
+50,479
| New | +$584K | ﹤0.01% | 2609 |
|